跳至主要内容
临床试验/NCT00986921
NCT00986921已完成不适用

Mifepristone vs. Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks

Boston University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2009年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Time for Completion of Procedure

研究概览

简要总结

Women who are requesting pregnancy termination at 14-16 weeks, who would normally have osmotic dilator insertion the day before their procedure, would be asked if they wanted to participate. Participants would be randomized to two groups: first, dilator insertion as usual, or second, mifepristone taken the day before the procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women aged 18-45 having pregnancy termination at 14-16 weeks

排除标准

  • multiple gestation, pre-existing infection, contraindication to osmotic dilators, unable to obtain proper consent

研究组 & 干预措施

mifepristone

Experimental

women in the mifepristone are would take mifepristone 200 mg for cervical preparation the day before their procedure, and not have dilators inserted. In this group, the sstandard procedure of osmotic dilator insertion is NOT performed.

干预措施: mifepristone 200 mg (Drug)

Osmotic dilator insertion

Active Comparator

Women assigned to this arm would have the standard procedure for cervical preparation, which is insertion of osmotic dilators the day before the abortion procedure

干预措施: osmotic dilator insertion (Device)

结局指标

主要结局

Time for Completion of Procedure

时间窗: Performance and completion of the abortion procedure takes 10-20 minutes. The length of the procedure is measured. The procedure occurs approximately 24 hours after enrollment.

Minutes, from the time of the start of the procedure (speculum insertion) to the conclusion of the procedure (speculum removal)

次要结局

  • Assessment of Ease of Procedure by Operator(It is administered shortly after the primary outcome, which is one day after enrollment. The study is complete at that point.)
  • Moderate or Severe Pain Overnight(Overnight)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lynn Borgatta

Principal investigator

Boston University

研究点 (1)

Loading locations...

相似试验